Navigation Links
Intercept Pharmaceuticals Raises $25 Million Series B Financing
Date:1/25/2010

NEW YORK, Jan. 25 /PRNewswire/ -- Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the completion of a $25 million Preferred Series B financing by its majority shareholder Genextra S.p.A.

Dr. Mark Pruzanski, founder, President and CEO commented, "This financing is recognition of the success we have had advancing our lead compounds INT-747 and INT-777. Genextra's strong backing will enable us to advance our clinical programs while continuing to build our pipeline of novel small molecules targeting FXR, TGR5 and other bile acid receptors."

In conjunction with the financing, Dr. Lorenzo Tallarigo, CEO of Genextra and Intercept director, is assuming the role of Chairman. Dr. Tallarigo stated, "This financing adds substantially to Genextra's investment in Intercept. With two positive Phase II studies last year, the company has made great progress in validating the therapeutic utility of INT-747 and the novel class of compounds it belongs to more broadly."

About Intercept Pharmaceuticals

Intercept is a clinical stage biopharmaceutical company focused on discovering and developing small molecule drugs for the treatment of chronic fibrotic and metabolic diseases. The company's most advanced programs are focused on the development of modified bile acids that are selective for FXR, a nuclear receptor, and TGR5, a G protein-coupled receptor. Bile acid signaling through these receptors regulates key aspects of lipid, glucose and overall energy metabolism, while also serving to maintain the functional integrity of the liver, intestine and kidney, organs that are exposed to bile acid flux.

About INT-747 (first-in-cla
'/>"/>

SOURCE Intercept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
2. Intercept Pharmaceuticals FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
3. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
4. Amylin Pharmaceuticals to Webcast Year-End Financial Results
5. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
6. Sagent Pharmaceuticals Launches Pamidronate Disodium Injection
7. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
8. Barclays Wealth Recommends Increasing Exposure to Laggard Sectors Including Consumer Staples, Pharmaceuticals and Telecoms
9. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
10. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
11. Oramed Pharmaceuticals Announces Filing of Two Registration Statements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Isis ... that it has earned a $4 million milestone ... ) associated with the initiation of a Phase ... multi-drug resistant (MDR), gram-negative bacterial infections.  The Phase ... to evaluate the efficacy and safety of plazomicin ...
(Date:9/17/2014)... Sept. 17, 2014 Sutro Biopharma, a biopharmaceutical ... the biopharmaceutical division of Merck KGaA, Darmstadt, ... the United States and ... license agreement to develop antibody drug conjugates (ADCs). ADCs ... drug. The antibody is thought to specifically target and ...
(Date:9/17/2014)... Pa. , Sept. 17, 2014  Fortune Oil ... officially changed its name to Manzo Pharmaceuticals, Inc. with ... to take effect today, September 17, 2014. Also taking ... The approval is a pivotal event in ... . Mr. Manzo explained, "We could not proceed with ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 2Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 3
... 3, 2011 Coast Dental Services, Inc., announced today ... the assets of Dental Technology, Inc. (DTI), doing business ... licensed  health care service plan. DTI and its subsidiaries ... Texas, employing 1,200 staff members, including 130 dentists.  The ...
... 3, 2011 The Food and Drug Administration says ... retail outlets that falsely claim to treat, prevent, or ... you’re taking a big risk unless you see a ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) View a ...
Cached Medicine Technology:Coast Dental to Acquire the Assets of SmileCare 2
(Date:9/17/2014)... September 17, 2014 Dr. Shervin Naderi, ... surgeons, has been recognized as a recipient of the 2014 ... only the best of the best as it honors physicians ... Dr. Naderi, who is affectionately known by his plastic surgeon ... handful of true rhinoplasty specialist surgeons in the ...
(Date:9/17/2014)... Steven Reinberg HealthDay Reporter ... The number of Americans dying from accidental overdoses of ... health officials reported Tuesday. Deaths from overdoses of ... climbed from 1.4 per 100,000 people to 5.4 ... Control and Prevention. That means about 3,000 people ...
(Date:9/17/2014)... one can say whether yoga provides clinical benefits to ... in the Journal of Psychiatric Practice , researchers ... with the condition who practice yoga. What the collective ... help, but it sometimes carries risks, too. , "There ... disorder," said lead author Lisa Uebelacker, associate professor (research) ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A  recent ... of a 24-year-old man named Advait Thakur who had ... caused by degenerative disc disease. This disease led to ... his nerve roots and causing severe pain. Leading spine ... and how it can lead to such severe pain, ...
(Date:9/17/2014)... 2014 The disability rights group Not Dead ... vigil against the World Federation of Right to Die Societies ... American group Final Exit Network is hosting the meeting, which ... group has scheduled a rally to open the protest vigil ... PM. , ”We are here to contradict the message of ...
Breaking Medicine News(10 mins):Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 2Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 3Health News:Survey finds benefits, risks of yoga for bipolar disorder 2Health News:Survey finds benefits, risks of yoga for bipolar disorder 3Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3Health News:Disability Rights Activists to Protest International Euthanasia Group Meeting in Chicago 2
... VILLAGE, Calif., Feb. 27 Riverview Medical,Center, ... recognized for service,excellence under the J.D. Power ... a strong commitment by Riverview,Medical Center to ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-a ), The service ...
... BOSTON, Feb. 27 Although,physician-scientists and supplement manufacturers ... sparring over multivitamins. In fact, half the,physicians on ... taking a,multivitamin themselves. In recent years, Harvard Men,s ... that even if they don,t,help, they won,t hurt. ...
... The Association for Professionals in Infection Control and ... selected by Blue Shield of California Foundation (BSCF) ... healthcare-associated infections (HAIs). , APIC will join BSCF ... Foundations innovative California Healthcare-Associated Infection Prevention Initiative to ...
... Arthritis Foundation to Launch the ,I ... Can with RA in the Kitchen(TM), Campaign, NEW ... approach to cooking, which involves using 70 percent,store-bought items and ... millions of busy Americans. Unknown to most, Lee,s signature,style was ...
... Feb. 27 /PRNewswire-FirstCall/ - (Imaging Dynamics Company,Ltd.) (TSX: ... image,quality and value, today announced that it was ... digital radiography system. This is the 7th,U.S. patent ... awarded to IDC in,countries around the world for ...
... that is an early indicator of kidney dysfunction in ... of Georgia researchers have found. , Microalbuminuria, excessive amounts ... among diabetics, says Dr. Gregory Harshfield, director of the ... reason, the few studies that have looked at adolescent ...
Cached Medicine News:Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 2Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 3Health News:It's Time to Reassess the Value, Safety of Multivitamin Use, Says Harvard Men's Health Watch 2Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 2Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 3Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 4Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 5Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 6Health News:IDC receives patent on dual energy imaging technology 2Health News:IDC receives patent on dual energy imaging technology 3Health News:Urine protein may be present before hypertension diagnosis in at-risk adolescents 2
... Accu-Temp Cauteries provide a ... for cauterization in a wide ... single use cautery is packaged ... cap to lock switch in ...
... provide a broad selection of tip ... variety of ophthalmic procedures. Each single ... with a safety cap to lock ... when not in use, and carries ...
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... Luminary LASIK Light Probes provide the surgeon ... the corneal interface to be easily visualized ... the Tindal effect and light scatter technique, ... debris, epithelial deposits, flap edge folds, corneal ...
Medicine Products: